The market cap is below the cash on hand. Q1 2026 just made that arithmetic alive.

Earnings swing violently with one variable — the polysilicon ASP — which collapsed from $30+/kg in 2022 to $5.25/kg in 2025 as Chinese nameplate capacity tripled past demand. The market is now offering the entire production engine for free plus 34¢ on every dollar of net cash, a setup that exists when investors expect the cash itself to bleed away. The Q1 2026 print is exactly that bleed: revenue collapsed 88% sequentially to $26.7M and operations burned ~$150M in a single quarter.

One print rolled back the entire 2H 2025 recovery thesis.

• Revenue $26.7M, 88% down from Q4. Sales volume fell to 4,482 MT against 38,167 MT a quarter earlier — even as production held at 43,402 MT, above guidance. Daqo is making polysilicon faster than the Chinese market is taking it.
• Operating loss back to $151M. Q3 and Q4 2025 had narrowed to roughly -$20M each on a slow climb out of the 2024 trough. One quarter just printed worse than every period of FY25 — including Q2 2025's -108% gross margin.
• Stock down 12.9% on the day; death cross fired March 16. Price now sits 27% below its 200-day average and 35.8% below year-end 2025. The bull's primary policy catalyst was already impaired in January when SAMR halted the $7B consolidation SPV on antitrust grounds.

The $1.94B cash buffer is real on the balance sheet — and not real in the way consensus is pricing it.

• Buyback authorized August 2025: $100M. Executed by March 2026: ~$1M. One percent at sub-0.25× book and below cash. The IR head's own Q3 framing — 'the stock had run from $23 to $31, we wanted to purchase more shares, we were waiting' — is a textbook capital-allocation mistake disclosed verbatim.
• FY25 operating cash flow ($50M) almost exactly equals the SBC add-back ($56M). Operating cash before equity dilution is negative; cumulative two-year FCF is -$917M; capex is now running below depreciation. The 'burn already decelerated' framing is partly an accounting artifact.
• Four Form 144 sale notices in Sept-Dec 2025; CFO holds zero shares after a decade. Daqo is a foreign private issuer exempt from Form 4, so insider buys would be invisible — but no equivalent record has surfaced. The family's revealed preference is the cleanest read on whether the cash arb is real.